Product
Tobramycin
Name
Tobrex
INN Name
tobramycin
FDA Approved
Yes
7 clinical trials
1 organization
14 indications
2 documents
Indication
Bronchopulmonary DysplasiaIndication
BronchiectasisIndication
Cystic FibrosisIndication
PneumoniaIndication
FractureIndication
OpenIndication
Wounds and Injuries--InfectionsIndication
Antibacterial AgentsIndication
BoneIndication
Lower Extremity FractureIndication
Upper Extremity FracturesIndication
Wound InfectionIndication
SSIsIndication
Total Knee ArthroplastyClinical trial
Phase 1 Feasibility Trial of Inhaled Tobramycin in Preterm Infants With Bronchopulmonary DysplasiaStatus: Active (not recruiting), Estimated PCD: 2023-12-31
Clinical trial
A Study of the Clinical Benefit of Tobramycin Inhalation SolutionStatus: Active (not recruiting), Estimated PCD: 2024-01-31
Clinical trial
Acute Application Of Intrawound Antibiotic Powder In Open Extremity Fracture WoundsStatus: Completed, Estimated PCD: 2023-09-30
Clinical trial
Locally Applied Antibiotics for Infection Prophylaxis in Treatment of Open FracturesStatus: Terminated, Estimated PCD: 2019-03-07
Clinical trial
Does Prophylactic Local Tobramycin Injection Lower Open Fracture Infection Rates?Status: Recruiting, Estimated PCD: 2025-09-01
Clinical trial
IV Colistin for Pulmonary Exacerbations: Improving Safety and EfficacyStatus: Completed, Estimated PCD: 2020-09-10
Clinical trial
Drug Elution Profile and Minimum Inhibitory Concentration of Antibiotic-loaded Cement After Primary Total Knee ArthroplastyStatus: Completed, Estimated PCD: 2023-11-30
Document
DailyMed Label: TobramycinDocument
DailyMed Label: TobrexOrganization
Rebel Distributors Corp.